E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/3/2006 in the Prospect News Biotech Daily.

Advanced BioPhotonics, Beth Israel Deaconess enter into pilot research agreement

By Elaine Rigoli

Tampa, Fla., Aug. 3 - Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, has entered into an agreement with Advanced BioPhotonics, Inc. to participate in the company's multi-center clinical trial investigating dynamic infrared imaging in mapping vascular perforator blood vessels in plastic and reconstructive surgery procedures.

"Beth Israel Deaconess Medical Center is the fourth and final luminary medical center to join this multi-center trial. We continue to generate excitement and make steady progress in this plastic surgery application. Based on earlier work, our technology holds the promise of shortening procedure times and improving flap viability," senior vice president Robert P. Ellis said in a news release.

The agreement is for a period of one year.

The company said it will conclude the trial in September in preparation for commercial release of a reconstructive surgery application in the fourth quarter of 2006.

Advanced BioPhotonics based in Bohemia, N.Y., develops medical-imaging applications using infrared technology.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.